Ian Abercrombie is the Chief Operating Officer at NuCana BioMed, an oncology-focused biopharmaceutical company. Based in Edinburgh, United Kingdom.
Ian Abercrombie is the Chief Operating Officer at NuCana BioMed, an oncology-focused biopharmaceutical company. NuCana BioMed specializes in developing and commercializing the ProTide Technology Platform to transform chemotherapy into targeted therapy. Abercrombie joined NuCana BioMed in May 2012, bringing extensive experience from senior management roles at companies such as Caris Life Sciences, Genzyme, Bioenvision, and J&J.
Full founder directory · Investor directory · Company funding database · Fundraising library